Latest news
Ernexa appoints David Polinsky to board ahead of IND filing - Investing.comInvesting.com · Mon, 10 Aug 2026 13:34:23 GMTBiotech veteran with 25 years’ experience joins Ernexa board - Stock TitanStock Titan · Mon, 10 Aug 2026 13:01:00 GMTErnexa Therapeutics (NASDAQ: ERNA) details $9.5M loss and cash strategy - Stock TitanStock Titan · Thu, 06 Aug 2026 21:31:49 GMTPrice to sales forward of Ernexa Therapeutics Inc. – NASDAQ:ERNA - TradingViewTradingView · Tue, 04 Aug 2026 10:00:43 GMTErnexa Therapeutics Inc. Revenue Breakdown – NASDAQ:ERNAW - TradingViewTradingView · Tue, 04 Aug 2026 02:47:23 GMTErnexa Therapeutics (ERNA) Drops Nearly 5% as Bearish Pressure Builds Near Key Support - Market Profile - dars.gov.etdars.gov.et · Tue, 28 Jul 2026 19:46:10 GMT